A variant in the NCF1 gene, a pharmacogenomic finding about voriconazole, in the Dante Labs reports provided a precise ...
A University of Waterloo prototype combines preliminary E. coli experiments and multiscale models to assess an ...
GSK’s Hibsago brings a new mechanism of action to chronic hepatitis B, targeting the genetic instructions the virus uses to ...
Timeslife on MSN
6 tests in full body packages that rarely change your treatment
The appeal of a full body health package is easy to understand. One appointment, one bill, a printout that says you are fine.
New active ingredients for drugs to treat infections, cancer or other serious diseases are often based on substances originally discovered in microorganisms, plants or other living organisms.
Enzyme-embedded compostable polyesters degraded faster than enzyme-free controls in coastal and deep-sea tests, with near-complete breakdown within five months at 757 metres.
Hibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s ...
Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, ...
Enveric Biosciences Inc. (NASDAQ:ENVB) reported favorable outcomes from IND-enabling laboratory studies evaluating its ...
University of Bonn scientists reset 80-year-old blood cells to a molecular age under 20 in an Aging Cell study, reigniting ...
Publication of first ever head-to-head comparison of gut microbiome changes associated with novel oral preclinical PolC (pol IIIC*) inhibitors to linezolid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results